Citation Impact
Citing Papers
Using network analysis to explore co-occurrence patterns in soil microbial communities
2011 Standout
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Lung microbiota across age and disease stage in cystic fibrosis
2015
Spirometric values in Gypsy (Roma) children
2008
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
2014 Standout
Microbiota in health and diseases
2022 Standout
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus , Gram-Negative Bacteria, and Multiple Infections
2014
Early emergency department treatment of acute asthma with systemic corticosteroids
2001
Corticosteroids for preventing relapse following acute exacerbations of asthma
2007
Corticosteroids for hospitalised children with acute asthma
2003
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
Holding chambers versus nebulisers for beta-agonist treatment of acute asthma
2003
Recent advances in cystic fibrosis
2008
Bugs, Biofilms, and Resistance in Cystic Fibrosis
2009
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Cystic fibrosis
2016 Standout
Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation
2013
Cystic fibrosis
2003
Prevalence of fish and shellfish allergy
2016
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study
2013
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Microbes, metabolites, and the gut–lung axis
2019
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
2012
Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial
1997
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
2008
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
The oral microbiome in health and disease
2012 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Inhalers and nebulizers: which to choose and why
1996
The costs of asthma
1996
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
The Role of Lung and Gut Microbiota in the Pathology of Asthma
2020
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Revisiting the evidence on health and health care disparities among the Roma: a systematic review 2003–2012
2013 Standout
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial
2014
Normal spirometric reference values for Omani children and adolescents
2004
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
2006
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Response of preschool children with asthma symptoms to fluticasone propionate
2001
The microbiota of the respiratory tract: gatekeeper to respiratory health
2017
Resistencia de Helicobacter pylori al metronidazol y a la claritromicina en España. Una revisión sistemática
2001
National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma Care
1996
Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report
2008
Delivery of Inhaled Medication to Children
1997
Food allergy: nuts and tree nuts
2006
Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review)
2014
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
2011
Monitoring Respiratory Disease Severity in Cystic Fibrosis
2009
Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma
2001
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
2014
Improved outcomes for hospitalized asthmatic children using a clinical pathway
2000
The microbiome of the lung
2012
Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study
2007
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
2009 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Nontuberculous mycobacteria
2013
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
2005
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis
2010
Disordered Microbial Communities in Asthmatic Airways
2010 Standout
Severe viral respiratory infections in infants with cystic fibrosis
1998
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes
2004
Spirometric Reference Values in Tunisian Children
2004
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Asthma
2000 Standout
Lung Function Reference Values in Chinese Children and Adolescents in Hong Kong
2000
Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation
2013
The Effect of Inhaled Budesonide on Symptoms, Lung Function, and Cold Air and Methacholine Responsiveness in 2- to 5-year–old Asthmatic Children
2000
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Tannic Acid with Antiviral and Antibacterial Activity as A Promising Component of Biomaterials—A Minireview
2020 Standout
Quantitative Analysis of the Human Airway Microbial Ecology Reveals a Pervasive Signature for Cystic Fibrosis
2012
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
2006 Standout
Health Benefits of Nut Consumption
2010 Standout
Pneumonectomy in cystic fibrosis
1999
Actinomyces and Related Organisms in Human Infections
2015 Standout
A Review on Anti-Inflammatory Activity of Monoterpenes
2013 Standout
Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren.
1996
British Guideline on the Management of Asthma
2008
House dust mite control measures for asthma
2008
Infectious triggers of pediatric asthma
2003
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Prevalence of asthma and comorbid allergy symptoms in Singaporean preschoolers.
2006
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
2010
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology
2015
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Treatment of Childhood Atopic Dermatitis and Economic Burden of Illness in Asia Pacific Countries
2015 Standout
The oral microbiota: dynamic communities and host interactions
2018 Standout
Congenital Malformations
1953 Standout
New concepts in the pathology of congenital lung malformations
2003
Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures
2012
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of Gary Connett being referenced
Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches
2009
Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency
2005
A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital
1999
A Population-Based Study of Fish Allergy in the Philippines, Singapore and Thailand
2012
Molecular Microbiological Characterization of Preterm Neonates at Risk of Bronchopulmonary Dysplasia
2010
Cystic Fibrosis Diagnosed After 2 Months of Age Leads to Worse Outcomes and Requires More Therapy
2007
The use of culture-independent tools to characterize bacteria in endo-tracheal aspirates from pre-term infants at risk of bronchopulmonary dysplasia
2010
Bronchoscopic appearances of congenital lobar emphysema
1996
Acute intestinal obstruction as a presentation of cystic fibrosis in infancy
2007
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis
2012
Flexible fibre‐optic bronchoscopy in the management of lung complications in cystic fibrosis
1996
Effects of an acaricide on asthmatic children with house dust mite allergy
1994
Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis
1999
Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review
2018
Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer
2010
Lung resection in cystic fibrosis patients with localised pulmonary disease.
1996
Prevention of viral induced asthma attacks using inhaled budesonide.
1993
Paediatric evaluation of difficult asthma
2000
Use of pulse oximetry in the hospital management of acute asthma in childhood
1993
Cephalosporin-3′-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms
2016
Lung function reference values in Singaporean children aged 6-18 years.
1994
112 Can vancomycin injection be nebulised successfully?
2011
Prednisolone and salbutamol in the hospital treatment of acute asthma.
1994
Approaching "asthma" in pre-school children.
1992
Use of budesonide in severe asthmatics aged 1-3 years.
1993
Faecal Elastase 1: A Marker of Exocrine Pancreatic Insufficiency in Cystic Fibrosis
1999
The cost effectiveness of budesonide in severe asthmatics aged one to three years
1993
Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis
2006